Antibiotics Flashcards

1
Q

What are antibiotics?
Where did they come from?

What do we do to make them useful in medicine?

A

Natural products of fungi and bacteria - soil dwellers
- they result in natural antagonism and selective advantage
- kill or inhibit the growth of other microorganisms

  • mostly derived from natural products by fermentation
  • then modified chemically to increase pharmacological properties and increase the anti-microbial effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When do we use antibiotics?

Acute?
Exposure?

When is it INAPPROPRIATE

A

Treatment of BACTERIAL INFECTIONS

prophylaxis : close contacts of transmissible infection, prevention of infection, peri-operative cover

inappropriate - VIRAL SORE THROAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What makes a good antibiotic?

8 things

A

Selective toxicity

Good killing activity

Slow emergence of resistance

Narrow spectrum of activity

non-toxic to host

long plasma half life (low dosage)

oral/parental dosing forms (compliance)

no interaction with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the reason for selective toxicity?

What is the aim of selective toxicity?

Why is it not appropriate to use Abx with viruses/fungi?

A

Mechanism of action - exploits the differences in METABOLIC and STRUCTURAL differences between the host and the pathogen

YOU WANT TO HARM MICROORGANISMS - not host!

difficult for viruses - as they are intracellular organisms and go into the hosts cells

Difficult for fungi as they share similar components to host cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the TWO different types of mechanisms of Abx with regards to bacteria?

Good KILLING activity

A

Bactericidal and Bacteriostatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are bactericidals
When are they used?
Host/Infection

A
  • Kill bacteria
  • Used when Host defense mechanisms are IMPAIRED
  • required in DIFFICULT TO TREAT infections - endocarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are bacteriostatic?
When are they used?
Host/Infection

A

Inhibit the bacteria

used when host defence mechanisms are intact

Used successfully in many infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why do we want slow emergence of resistance?

What normally happens when bacteria mutate?

What happens if Abx are used with bacteria?

What can Abx do to some bacteria?

A

Most mutations leading to resistance are associated with a fitness cost –> die out BUT they can survive if antibiotics are present

Using Abx - selects out the resistance bacteria which survive and multiply

Different antibiotics have different capacity to induce resistance

Some bacteria have inducible resisistance mechanisms triggered by certain antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Spectrum of activity….
When do we used broad vs narrow?

A

Different stage of infection require different antibiotics

Prior to knowing cause : BROAD spectrum

after finding cause: results of cultures/investigations are back - TARGET - NARROW SPECTRUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a conseqeunce of Abx- natural flora?

Condition that occurs after losing natural flora?

Which Abx is this associated with? CLEAN FLOORS BREAK COLON

A

Loss of natural flora due to Abx use - leads to bacterial or pathogen OVERGROWTH

(due to lack of microbial anatagonism normal flora normally OUTGROW pathogens)

Antibiotic associated colitis
- clindamycin, broad spectrum lactams, fluoroquinolones)

  • psuedomembranous colitis - leads to C.DIFFICILE OVERGROWTH

Symptoms
- ulcerations
- severe diarrhoea
- serious hospital cross infection risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What indicates the non-toxicity to host?

MIC vs Toxic effect

What indicates safety? Large or small

A

Therapeutic index - ratio comparing the blood concentration at which a drug becomes TOXIC and ratio at which it is EFFECTIVE

Active dose (MIC) vs toxic effect

Larger TI - safer the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are two examples of narrow TI
What does this indicate

A

Narrow TI indicates TOXICITY

Ototoxic : aminoglycosides

Nephrotoxic : vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why do we want a long plasma half life?

A

Once a day administration
- more stable concentration
- better compliance
- easy administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why do we need a range of dosing forms?

When is oral not an option?

What is ideal for sepsis patients?

What is the risk with IV?

A

IV/IM/PO/Topical

More flexibility

Some patients cannot take PO - cannot absorb/cannot swallow

Septicemia - IM due to poor blood flow

IV - INFECTION in cannula, cellulitis at cannula site (strep pyogenes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are example of interactions with Abx and other drugs?

OCP - Rid
Warfarin - FMS

A

Pharmacokinetic - ADME

WARFARIN - effect is POTENTIATED via antibiotcs
- fluoroquinolones, macrolides, sulfonamids INHIBIT metabolism

Rifamcin - rids the pill !! affects OCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanisms of action of antibiotics?

Can people not make cells?

5 x routes

A
  1. Cell wall synthesis
  2. Protein synthesis
  3. Nucleic acid synthesis
  4. Metabolic Pathways
  5. Membrane Functions
17
Q

What is the TARGET of cell wall synthesis with antibiotics?

Where does penicillin target?
What type of Abx is penicillin?

Where does vancomycin target?
What type of Abx is vancomycin?

A

Cell walls of gram positive and gram negative bacteria have PEPTIDOGLYCAN WALL

  • made up of Penicillin binding proteins and D-ala D-ala peptide side chains
  • Penicllin - target PBP - prevent crosslinking
  • Beta Lactam
  • Vancomycin - binds to D-ala D-ala
  • glycopeptides

DISRUPTS cell wall peptidoglycan - leads to bacterial lysis

18
Q

What do antibiotics target in protein synthesis?

RIBOSOMES

A

Abx - INHIBIT 30s RIBOSOMES and 50s RIBOSOMES

19
Q

Examples of Antibiotics for 30S ribosomes?

AT 30 Proteins

A

30S examples:

A=A
Aminoglycosides (gentamicin, amikacin) - bind near A side - premature termination of translation of mRNA

T=T
Tetracyclines (doxycycline) - prevent binding of t-RNA to A site

20
Q

What are examples of 50s inhibitors for protein synthesis

“CML STOPs Protein”

A

Chloramphenicol - interact with peptidyl transferase cavity of 50s subunit

cause premature detachment of incomplete peptide chains =

Macrolides - erythromycin,

Linosamides - clindamycin
streptogramins

Oxazolidinones (linezolid)
- prevent formation 70s initiation complex

21
Q

What Abx targets nucleic acid synthesis?

A

Fluoroquinolones (ciprofloxacin, levofloxacin) - inhibit the bacterial enzyme involved in protein synthesis (DNA gyrase)

22
Q

What is required by all bacterial cells for growth?

How do antibiotics affect this metabolic pathway?

SOME THINGS STOP FA

A

Folic acid is required by all bacterial cells

SULFOMAMIDES
TRIMETHOPRIM

inhibit folic acid synthesis

23
Q

Cell Membrane Function - how to Abx stop this?

Polly - Negative - Leak

A

Polymyxins - Abx are positively charged so they are attracted to the negatively charged bacterial membrane (gram negative)

Polymyxins insert into the cell membrane of bacteria

Leakage of bacterial cell contents

Lysis of bacterial cell

24
Q

What is termed a resistant bacteria in terms of Abx resistance?

A

Resistant organism is one that will NOT BE inhibited or killed by an antibacterial agent @ concentrations of the drug at normal dosage

25
Q

Mechanisms of resistance?

A

Modification of target site

Use of alternative pathway (folic acid)

Lack of access to target site via reduction in permeability or efflux pumps or biofilms

Inactivation/destruction of antibiotic

26
Q

What can staph aureus do to modify the target site of Abx (beta lactams)

What does it prevent?

A

Staph aureus - when treated with beta-lactams (bind to PBP)

Staph aureus: acquires the MecA gene - makes PBP2 instead which has LOW AFFINITY for beta-lactam (cannot bind therefore not antibiotic cell wall synthesis destruction)

Prevents Cell wall synthesis destruction

27
Q

What can bacteria do to avoid metabolic pathway disruption

A

Sulfonamides - target the folic acid synthesis pathway

Resistant bacteria - produce extra PABA or develop alternative pathway

28
Q

How can bacteria reduce access to target site?

A

Reduce permeability - loss of outer membrane porins (pseudomonas aeruginosa)

Efflux pumps - located in plasma membrane (expel toxic/waste substances from cytoplasm) e.g. MexAB-OprM pump

Biofilms - polymicrobial - form a the site of foreign bodies (prostehtic joints)
bacteria secrete a protective matrix

29
Q

What can beta-lactams do to inactivate Abx

What can aminoglycosides do to inactivate Abx

A

Beta lactams - USE beta-lactamases to inactivate

Aminoglycosides - use aminoglycoside modifying enzymes to inactivate